Table 3.
Summary statistics of AR symptom severity.
| Parameter | Active (N = 33) | Placebo (N = 32) | P-value |
|---|---|---|---|
| Visit 1 (0 Days) | |||
| Very severe | 14 (42.42 %) | 7 (21.87 %) | .2396 |
| Severe | 19 (57.57 %) | 24 (75.00 %) | |
| Moderate | 0 (00.00 %) | 1 (3.12 %) | |
| Visit 2 (5 days) | |||
| Very severe | 1 (3.03 %) | 3 (9.375 %) | .0561 |
| Severe | 23 (69.69 %) | 27 (84.37 %) | |
| Moderate | 9 (00.00 %) | 2 (6.25 %) | |
| Visit 3 (15 days) | |||
| Severe | 1 (3.03 %) | 21 (65.62 %) | .0004 |
| Moderate | 16 (48.48 %) | 11 (34.37 %) | |
| Very mild | 11 (33.33 %) | 0 (00.00 %) | |
| Mild | 3 (9.09 %) | 0 (00.00 %) | |
| Absent | 2 (6.06 %) | 0 (00.00 %) | |